logo

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Pathologica LLC

Calculating rank
USPTO Granted Patents = 13

% Expired Patents = 69.2



Forward Citations = 62

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal John McKearn (9 out of 15 patents)

silverMedal Jeremy T Blitzer (9 out of 14 patents)

bronzeMedal Kenneth G Hadlock (2 out of 12 patents)

4.  Hope Lancero (2 out of 2 patents)

5.  Stephanie Yu (2 out of 2 patents)

6.  Hien Kim Do (2 out of 2 patents)

7.  Michael S McGrath (2 out of 26 patents)

8.  Tennore M Ramesh (1 out of 5 patents)

9.  Sean Scott (1 out of 5 patents)

10.  Laurence J Marton (1 out of 20 patents)

11.  Jeremy Blitzer (1 patent)

12.  Michael S Mcgrath (6 patents)

13.  John Mckearn (0 patent)

14.  Kenneth Hadlock (0 patent)

15.  Hien Do (0 patent)


13 patents:

1. 10881626 - Controlled release oral pharmaceutical dosage forms comprising MGBG (2021-01-05),
2. 10350178 - Methods and compositions for treatment of demyelinating diseases (2019-07-16),
3. 10292950 - Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing (2019-05-21),
4. 10085955 - Methods and compositions for treatment of demyelinating diseases (2018-10-02),
5. 9867794 - Regulation of osteopontin (2018-01-16),
6. 9675566 - Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing (2017-06-13),
7. 9668988 - Controlled release oral pharmaceutical dosage forms comprising MGBG (2017-06-06),
8. 9616035 - Pharmaceutical for oral delivery comprising MGBG and methods of treating disease (2017-04-11),
9. 8858991 - Delayed release oral pharmaceutical dosage forms comprising MGBG (2014-10-14),
10. 8445540 - Regulation of osteopontin (2013-05-21),
11. 8258186 - Pharmaceutical for oral delivery comprising MGBG (2012-09-04),
12. 8198334 - Methods for modulating macrophage proliferation in ocular disease using polyamine analogs (2012-06-12),
13. 7198946 - Screening for agents effective in decreasing abnormal macrophages associated with amyotrophic lateral sclerosis (2007-04-03),
Company Overview
Pathologica LLC is a biotechnology company based in San Francisco, California, specializing in the development of innovative diagnostic solutions. The organization focuses on leveraging advanced technologies to enhance disease detection and management, particularly in the field of pathology. By integrating cutting-edge research with practical applications, Pathologica aims to improve patient outcomes through more accurate and efficient diagnostic processes, contributing to the evolving landscape of healthcare technology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Pathologica LLC USPTO Patent Assignee Logo
13 Patents

#355 in San Francisco, CA

#5,664 in California

#23,860 in US

#45,085 in the World

San Francisco, CA (US)
San Francisco, CA, United States of America

Pathologica LLC

Forward Citations = 62

10 inventors:

goldMedal John McKearn (9 out of 15 patents)

silverMedal Jeremy T Blitzer (9 out of 14 patents)

bronzeMedal Kenneth G Hadlock (2 out of 12 patents)

4.  Hope Lancero (2 out of 2 patents)

5.  Stephanie Yu (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pathologica LLC. Retrieved from https://idiyas.com/company/pathologica

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…